Endogenous opioids and their receptors. Evidence for involvement in the postictal effects of electroconvulsive shock.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001341:Autonomic Nervous System / Q000502:physiology; D001794:Blood Pressure; D001921:Brain / Q000502:physiology; D004174:Diprenorphine / Q000494:pharmacology; D004361:Drug Tolerance; D004565:Electroconvulsive Therapy; D004569:Electroencephalography; D004723:Endorphins / Q000502:physiology*; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives / Q000494:pharmacology; D016308:Enkephalin, Leucine-2-Alanine; D004745:Enkephalins / Q000502:physiology; D006339:Heart Rate; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D010146:Pain / Q000503:physiopathology; D010902:Pituitary Gland / Q000502:physiology; D011311:Pressoreceptors / Q000502:physiology; D051381:Rats; D011957:Receptors, Opioid / Q000502:physiology*; D012684:Sensory Thresholds / Q000502:physiology; D014316:Tritium
D000927:Anticonvulsants; D004723:Endorphins; D004745:Enkephalins; D011957:Receptors, Opioid; D014316:Tritium; D004174:Diprenorphine; D009270:Naloxone; D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; D009020:Morphine